Treatment of Hypertension and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome

Takeki Suzuki, Shunichi Homma

Research output: Contribution to journalReview article

10 Scopus citations

Abstract

Metabolic syndrome (MetS), a concurrence of hypertension, abdominal obesity, impaired fasting glucose, and dyslipidemia, has been shown to be a risk factor for cardiovascular disease. Insulin resistance has been thought to be one of the pathophysiologies of the syndrome. Reduction of the underlying causes of MetS, such as obesity, physical inactivity, and atherogenic diet, is first-line therapy. Treatment of hypertension and other cardiometabolic risk factors of MetS is also required. This article reviews the treatment of the metabolic syndrome with a focus on the importance of lifestyle changes and treatment of hypertension.

Original languageEnglish (US)
Pages (from-to)1211-1223
Number of pages13
JournalMedical Clinics of North America
Volume91
Issue number6
DOIs
StatePublished - Nov 1 2007
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Treatment of Hypertension and Other Cardiovascular Risk Factors in Patients with Metabolic Syndrome'. Together they form a unique fingerprint.

  • Cite this